The r/MedSpa post asking for alternatives to a well-known telehealth platform is really asking a business question that has nothing to do with which vendor is best: how does a two-person operation add a new service line without either paying for a custom build or handing over a percentage of every sale, forever. The author says it plainly — running lean, just her and one other person, launching a GLP-1 or TRT offer, no budget for a big build, and no appetite for giving away a cut of every sale.
The specific regulatory and clinical questions that surround prescription service lines are not something this article will adjudicate; those depend on state rules, on who holds the license, and on advice from a healthcare attorney. What can be worked through here is the structural decision underneath the vendor question, because it repeats itself every time a small practice adds anything — a prescription line, a membership, a new device service — and the practitioners who get it wrong usually get it wrong in the same way.
The build-versus-cut decision, stated honestly
Every new service line has a payment structure, and there are only three shapes it can take. You build it and own it, which means a large up-front cost and a slow path to break-even, but the marginal revenue on every sale is yours. You rent it, which means a smaller or zero up-front cost and a permanent per-sale cut that never amortizes, no matter how many sales you make. Or you partner, which means sharing the economics in exchange for someone else carrying a piece of the risk and the workload.
The trap is comparing the first month of the first option against the first month of the second, because that comparison always favors renting. The honest comparison is cumulative: how many sales does it take before the build cost is recovered, and what does the total cut paid to the platform look like at the volume you actually expect over three years. A per-sale cut that looks trivial in month one becomes the largest line item on the P&L by year three, and it does not stop when you have paid more than a build would have cost. That is not an argument against renting — for a genuinely uncertain service line, renting is the correct way to buy information. It is an argument for knowing which one you are doing and for what period.
The decision also needs a defined review point. Renting is defensible as a validation phase; it is a much weaker position as a permanent state. Write down the volume at which the cut starts to exceed what a build or a purchase would cost, and treat that number as the date the decision gets revisited. Practices that never revisit it are the ones that discover, three years in, that they have paid for the platform many times over and still own nothing.
The three things you must own regardless of the structure
Whichever shape a service line takes, three assets determine whether the practice is a business or a reseller, and they should be settled before launch rather than after.
The patient record. Who holds the chart, where does it live, and what happens to it if the vendor changes terms or the relationship ends. A platform that keeps the clinical record is a platform that owns the patient relationship in every way that matters commercially, because the record is what makes the next visit a continuation rather than a new customer. Get a clear answer in writing about export, format, and ownership before the first patient is seen.
The clinical accountability. Who is the treating provider, under whose license does the encounter occur, and who carries the responsibility if something goes wrong. A vendor can supply software, logistics, and even a medical director, but it cannot absorb your professional responsibility. Any arrangement where the answer to "who is responsible for this patient's care" is a company rather than a named licensed person is one where the practitioner is carrying exposure she has not priced.
The pricing. The practice that sets its own prices and explains them can defend them. The practice that resells a platform's package at the platform's price has no margin to protect and nothing to negotiate with, and it discovers that when the platform raises its fee or changes its bundling and the practice's own menu has to follow.
The simpler version of the same decision, when the service is device-delivered
There is a version of this choice where the economics are much easier, and it is worth naming because it is available to nearly every practice: services delivered by equipment the practice owns. Here the build-versus-cut question collapses, because there is no ongoing platform percentage to negotiate. The device is a one-time capital cost, the consumables are known, and every session delivered after break-even contributes at full margin.
That economics is what makes a multi-modality machine the standard first purchase for a small operator expanding a menu. A unit such as this 14-in-1 hydra dermabrasion salon facial machine is the representative case: instead of adding one service and one revenue stream, one purchase covers a set of treatment steps that can be assembled into several distinct menu items, which is the only way a two-person operation gets menu breadth without a capital programme. The trade-off is real — a machine that does many things rarely does any single one as well as a dedicated unit — but for a practice whose problem is breadth rather than depth, it is the cheapest way to own the capability outright.
Two cautions belong with it. The first is scope: what an esthetician or a nurse may perform varies by state and by license, and a device the practice is not permitted to operate is inventory rather than revenue. Confirm before purchase, not after. The second is that owning the equipment also means owning the training and the protocol, which is the part new buyers consistently underestimate. A machine without a written protocol is a machine that gets used inconsistently and then blamed.
What a lean operator should actually do first
Before choosing a vendor for anything, four questions produce more clarity than any product comparison. What exactly do I own at the end of this arrangement — the record, the brand relationship, the pricing, the equipment? What is the total cost of the per-sale cut at realistic three-year volume, compared with the one-time cost of owning it? Who is clinically and legally accountable, by name and license? And what is the trigger that makes me revisit the arrangement — a volume, a date, or a change in the vendor's terms?
A practice that can answer those four can rent with a clear head or build with a clear budget, and either choice is defensible. A practice that cannot answer them is not choosing a structure at all; it is accepting whatever the first vendor's contract happens to say, and discovering the terms later — which is the expensive way to learn that the cut never amortizes and the record was never quite yours.